Guide price only. Final cost is confirmed after assessment.
Meniscus replacement at the London Cartilage Clinic represents a cutting-edge surgical solution for individuals with severe meniscal damage or previous removal. This procedure involves replacing the damaged or missing meniscus - a crucial cartilage in the knee joint - with a donor graft. This surgery is crucial for maintaining knee stability, reducing pain, and delaying arthritis onset.
Reviewed byProfessor Paul Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertise
Meniscus replacement is considered when the native meniscus is severely damaged or absent, and symptoms continue despite structured non-operative care.
The goal is to restore cushioning and load distribution inside the knee, reducing pain and helping delay further cartilage wear.
Surgery is usually performed arthroscopically, using specialised instruments to prepare the knee and secure the donor graft in a stable position.
Recovery timelines vary, often ranging from 3 to 9 months depending on tissue healing, rehabilitation quality, and activity goals.
At London Cartilage Clinic, treatment planning and follow-up are handled by a specialist cartilage team to maximise graft protection and long-term knee function.
Meniscus replacement is a surgical procedure to replace a damaged or missing meniscus in the knee, aiming to restore joint stability and alleviate pain.
Ideal candidates are between 30 to 55 years old, not obese, with stable knee ligaments and minimal knee arthritis.
Recovery varies, typically ranging from 3 to 9 months, depending on the individual’s condition and adherence to rehabilitation.
While rare, risks include knee stiffness, bleeding, infection, or the need for additional surgery.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
MACI recovery requires nine to twelve months, but the timeline is structured in phases: patients return to seated work within two weeks, normal walking by three months, jogging from month seven, and competitive sport from month twelve.
ChondroFiller is an acellular collagen scaffold that recruits the body's own progenitor cells to repair focal cartilage defects, but only when damage is confined to a single defined area of an otherwise structurally sound joint.
Bone-on-bone ankle osteoarthritis can be treated by fusing the joint permanently or replacing it to preserve motion; the TARVA trial found both procedures produced comparable functional gains. Selection between them depends on patient factors including age, activity level, and the state of neighbouring joints.
